Literature DB >> 16288487

A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999.

Indro Chakrabarti1, Myles Cockburn, Wendy Cozen, Ya-Ping Wang, Susan Preston-Martin.   

Abstract

BACKGROUND: There have been reports that the incidence rates of brain tumors have increased over the past few decades, but most have considered all brain tumors together. The authors analyzed the pattern of glioblastoma multiforme (GBM) occurrence in Los Angeles County, California to shed light on the incidence and descriptive epidemiology of this type of brain tumor.
METHODS: Data were obtained from the Los Angeles County Cancer Surveillance Program. Incidence rates were analyzed by gender, race, age at diagnosis, period of diagnosis (1974-1981, 1982-1988, or 1989-1999), and socioeconomic status (SES). In addition, data were stratified according to anatomic subsite. A multivariate model describing changes in rates by each of these variables was constructed.
RESULTS: Age-specific incidence rates (ASIR) rose sharply after age 30 years. The peak ASIR was at age 70-74 years in males and at age 75-79 years in females. The age-adjusted incidence rate (AAIR) of GBM increased from 1974 to 1999 by an estimated 2.4% per year among males and 2.8% per year among females. Overall, males had a 60% increased risk of brain tumors compared with females. Males had a higher incidence of GBM compared with females at each anatomic subsite except the posterior fossa. The largest male:female ratio occurred in the occipital lobes. Non-Latino whites had the highest incidence rates (2.5 per 100,000) followed by Latino whites (1.8 per 100,000), and blacks (1.5 per 100,000). After 1989, compared with the period before magnetic resonance imaging (MRI) was available, there was an increase in GBM incidence rates among those with of higher SES that was most pronounced in females. The incidence of GBM was highest for frontal lobe tumors and for tumors that involved two or more lobes (overlapping tumors), followed by tumors in the temporal and parietal lobes. In the multivariate analysis, year of diagnosis, SES, gender, race (Latino but not black), site, and age at diagnosis all were important predictors of incidence rate.
CONCLUSIONS: GBM incidence increased in Los Angeles County over the last 30 years and especially after 1989, suggesting that the introduction of MRI may have contributed to the increase. Individuals older than age 65 years experienced the greatest increase in incidence over time. Older age, male gender, higher SES, and non-Latino white race increased the risk of GBM. Previously unreported incidence rates for GBM among Latino whites were significantly lower than among non-Latino whites but were intermediate between non-Latino whites and blacks. Copyright 2005 American Cancer Society.

Entities:  

Mesh:

Year:  2005        PMID: 16288487     DOI: 10.1002/cncr.21539

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  66 in total

1.  Racial/ethnic differences in survival among elderly patients with a primary glioblastoma.

Authors:  Jill S Barnholtz-Sloan; John L Maldonado; Vonetta L Williams; William T Curry; Elizabeth A Rodkey; Frederick G Barker; Andrew E Sloan
Journal:  J Neurooncol       Date:  2007-05-26       Impact factor: 4.130

2.  Cancer mortality among German aircrew: second follow-up.

Authors:  Hajo Zeeb; Gaël P Hammer; Ingo Langner; Thomas Schafft; Sabrina Bennack; Maria Blettner
Journal:  Radiat Environ Biophys       Date:  2009-10-16       Impact factor: 1.925

Review 3.  Incorporation of biomarkers in phase II studies of recurrent glioblastoma.

Authors:  Toni Rose Jue; Elizabeth Hovey; Sara Davis; Oliver Carleton; Kerrie L McDonald
Journal:  Tumour Biol       Date:  2014-12-23

4.  Stereotactic biopsy in elderly patients: risk assessment and impact on treatment decision.

Authors:  Stephanie G Kellermann; Christina A Hamisch; Daniel Rueß; Tobias Blau; Roland Goldbrunner; Harald Treuer; Stefan J Grau; Maximilian I Ruge
Journal:  J Neurooncol       Date:  2017-06-21       Impact factor: 4.130

Review 5.  Treating glioblastoma in the elderly.

Authors:  Jaime Gállego Pérez-Larraya; Jean-Yves Delattre
Journal:  CNS Oncol       Date:  2012-11

Review 6.  The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis.

Authors:  Paula de Robles; Kirsten M Fiest; Alexandra D Frolkis; Tamara Pringsheim; Callie Atta; Christine St Germaine-Smith; Lundy Day; Darren Lam; Nathalie Jette
Journal:  Neuro Oncol       Date:  2014-10-13       Impact factor: 12.300

7.  Utilization of hypofractionated radiotherapy in treatment of glioblastoma multiforme in elderly patients not receiving adjuvant chemoradiotherapy: A National Cancer Database Analysis.

Authors:  Brian Bingham; Chirayu G Patel; Eric T Shinohara; Albert Attia
Journal:  J Neurooncol       Date:  2017-12-05       Impact factor: 4.130

Review 8.  Immunotherapy for brain cancer: recent progress and future promise.

Authors:  Christopher M Jackson; Michael Lim; Charles G Drake
Journal:  Clin Cancer Res       Date:  2014-04-25       Impact factor: 12.531

Review 9.  End-of-life symptoms and care in patients with primary malignant brain tumors: a systematic literature review.

Authors:  Tobias Walbert; Muhib Khan
Journal:  J Neurooncol       Date:  2014-02-13       Impact factor: 4.130

10.  Does risk of brain cancer increase with intracranial volume? A population-based case control study.

Authors:  Even Hovig Fyllingen; Tor Ivar Hansen; Asgeir Store Jakola; Asta Kristine Håberg; Øyvind Salvesen; Ole Solheim
Journal:  Neuro Oncol       Date:  2018-08-02       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.